Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis

Abstract

The global prevalence of obesity currently exceeds 1 billion people and is accompanied by an increase in the aging population. Obesity and aging share many hallmarks and are leading risk factors for cardiometabolic disease and premature death. Current anti-obesity and pro-longevity pharmacotherapies are limited by side effects, warranting the development of novel therapies. The gut microbiota plays a major role in human health and disease, with a dysbiotic composition evident in obese and aged individuals. The bidirectional communication system between the gut and the central nervous system, known as the gut-brain axis, may link obesity to unhealthy aging. Modulating the gut with microbiome-targeted therapies, such as biotics, is a novel strategy to treat and/or manage obesity and promote longevity. Biotics represent material derived from living or once-living organisms, many of which have therapeutic effects. Pre-, pro-, syn- and post-biotics may beneficially modulate gut microbial composition and function to improve obesity and the aging process. However, the investigation of biotics as next-generation therapeutics has only just begun. Further research is needed to identify therapeutic biotics and understand their mechanisms of action. Investigating the function of the gut-brain axis in obesity and aging may lead to novel therapeutic strategies for obese, aged and comorbid (e.g., sarcopenic obese) patient populations. This review discusses the interrelationship between obesity and aging, with a particular emphasis on the gut microbiome, and presents biotics as novel therapeutic agents for obesity, aging and related disease states.

Keywords

Microbiome / obesity / aging / gut-brain axis / prebiotics / probiotics / postbiotics / therapeutics

References

[1] Frasca D.Several areas of overlap between obesity and aging indicate obesity as a biomarker of accelerated aging of human B cell function and antibody responses.Immun Ageing2022;19:48 PMCID:PMC9598013

[2] Boutari C.A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on.Metabolism2022;133:155217 PMCID:PMC9107388

[3] Golden A.Obesit’s impact.Nurs Clin North Am2021;56:xiii-iv

[4] Afshin A, Forouzanfar MH, Reitsma MB, et al; GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years.N Engl J Med2017;377:13-27 PMCID:PMC5477817

[5] Schnabel F,Wollnik B.Premature aging disorders: a clinical and genetic compendium.Clin Genet2021;99:3-28

[6] United Nations, Department of Economic and Social Affairs Population Division. World Population Prospects 2022: Summary of Results. Available from: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/wpp2022_summary_of_results.pdf. [Last accessed on 15 May 2024]

[7] Li X,Zhang J.Accelerated aging mediates the associations of unhealthy lifestyles with cardiovascular disease, cancer, and mortality.J Am Geriatr Soc2024;72:181-93 PMCID:PMC11078652

[8] Rudnicka E,Podfigurna A,Smolarczyk R.The World Health Organization (WHO) approach to healthy ageing.Maturitas2020;139:6-11 PMCID:PMC7250103

[9] Kennedy BK,Brunet A.Geroscience: linking aging to chronic disease.Cell2014;159:709-13 PMCID:PMC4852871

[10] Li Z,Ren Y.Aging and age-related diseases: from mechanisms to therapeutic strategies.Biogerontology2021;22:165-87 PMCID:PMC7838467

[11] Xue QL.The frailty syndrome: definition and natural history.Clin Geriatr Med2011;27:1-15 PMCID:PMC3028599

[12] López-Otín C,Partridge L,Kroemer G.The hallmarks of aging.Cell2013;153:1194-217 PMCID:PMC3836174

[13] López-Otín C,Partridge L,Kroemer G.Hallmarks of aging: an expanding universe.Cell2023;186:243-78

[14] Global BMI Mortality Collaboration; Di Angelantonio E, Bhupathiraju ShN, Wormser D, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.Lancet2016;388:776-86 PMCID:PMC4995441

[15] Lung T,Tan EJ,Hayes A.Impact of overweight, obesity and severe obesity on life expectancy of Australian adults.Int J Obes2019;43:782-9

[16] Fontaine KR,Wang C,Allison DB.Years of life lost due to obesity.JAMA2003;289:187-93

[17] Ruze R,Zou X.Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments.Front Endocrinol2023;14:1161521 PMCID:PMC10161731

[18] Kolb R,Zhang W.Obesity and cancer: inflammation bridges the two.Curr Opin Pharmacol2016;29:77-89 PMCID:PMC4992602

[19] Dikaiou P,Adiels M.Obesity, overweight and risk for cardiovascular disease and mortality in young women.Eur J Prev Cardiol2021;28:1351-9

[20] Lee TH.From obesity to hippocampal neurodegeneration: pathogenesis and non-pharmacological interventions.Int J Mol Sci2020;22:201 PMCID:PMC7796248

[21] Caballero B.Humans against obesity: who will win?.Adv Nutr2019;10:S4-9 PMCID:PMC6363526

[22] Tam BT,Santosa S.Obesity and ageing: two sides of the same coin.Obes Rev2020;21:e12991

[23] Reyes-Farias M,Serra D,Sánchez-Infantes D.White adipose tissue dysfunction in obesity and aging.Biochem Pharmacol2021;192:114723

[24] Shinde AB,Wang QA.Brown adipose tissue heterogeneity, energy metabolism, and beyond.Front Endocrinol2021;12:651763 PMCID:PMC8092391

[25] Li QOY,Aragonés J.Age-dependent obesity and mitochondrial dysfunction.Adipocyte2017;6:161-6 PMCID:PMC5477719

[26] Zhang YX,Yang ZH,Li QF.Adipose tissue aging is regulated by an altered immune system.Front Immunol2023;14:1125395 PMCID:PMC9981968

[27] Man K,Vasanthakumar A.Resident and migratory adipose immune cells control systemic metabolism and thermogenesis.Cell Mol Immunol2022;19:421-31 PMCID:PMC8891307

[28] Kawai T,Scalia R.Adipose tissue inflammation and metabolic dysfunction in obesity.Am J Physiol Cell Physiol2021;320:C375-91 PMCID:PMC8294624

[29] Xu C,Rodrigues C.Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: a randomized, double-blind, placebo-controlled clinical trial.Clin Nutr ESPEN2018;24:148-55

[30] Hotamisligil GS.Inflammation, metaflammation and immunometabolic disorders.Nature2017;542:177-85

[31] Yu L,Tooze SA.Autophagy pathway: cellular and molecular mechanisms.Autophagy2018;14:207-15 PMCID:PMC5902171

[32] Aman Y,Hansen M.Autophagy in healthy aging and disease.Nat Aging2021;1:634-50 PMCID:PMC8659158

[33] Faghfouri AH,Payahoo L,Alivand M.PPAR-gamma agonists: potential modulators of autophagy in obesity.Eur J Pharmacol2021;912:174562

[34] Kalinkovich A.Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.Ageing Res Rev2017;35:200-21

[35] Wei S,Zhang Y,Gariani K.Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management.Front Endocrinol2023;14:1185221 PMCID:PMC10344359

[36] Batsis JA.Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.Nat Rev Endocrinol2018;14:513-37 PMCID:PMC6241236

[37] Polyzos SA.Sarcopenic obesity.Hormones2018;17:321-31

[38] Wagenaar CA,Navis GJ.Prevalence of sarcopenic obesity and sarcopenic overweight in the general population: the lifelines cohort study.Clin Nutr2021;40:4422-9

[39] Gao Q,Shang Y.Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis.Clin Nutr2021;40:4633-41

[40] Donini LM,Bischoff SC.Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.Obes Facts2022;15:321-35 PMCID:PMC9210010

[41] Lim S,Yoon JW.Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA).Diabetes Care2010;33:1652-4 PMCID:PMC2890376

[42] Crooks B,McLaughlin JT.Appetite, the enteroendocrine system, gastrointestinal disease and obesity.Proc Nutr Soc2021;80:50-8

[43] Westfall S,Kahouli I,Singh SP.Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.Cell Mol Life Sci2017;74:3769-87

[44] Jandhyala SM,Subramanyam C,Sasikala M.Role of the normal gut microbiota.World J Gastroenterol2015;21:8787-803 PMCID:PMC4528021

[45] O'toole PW.Gut microbiota: Changes throughout the lifespan from infancy to elderly.Int Dairy J2010;20:281-91

[46] Bäckhed F,Semenkovich CF.Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.Proc Natl Acad Sci U S A2007;104:979-84 PMCID:PMC1764762

[47] Rinninella E,Raoul P.The role of diet in shaping human gut microbiota.Best Pract Res Clin Gastroenterol2023;62-3:101828

[48] Hasan N.Factors affecting the composition of the gut microbiota, and its modulation.PeerJ2019;7:e7502 PMCID:PMC6699480

[49] Liu BN,Liang ZH.Gut microbiota in obesity.World J Gastroenterol2021;27:3837-50 PMCID:PMC8291023

[50] Ling Z,Cheng Y,Wu S.Gut microbiota and aging.Crit Rev Food Sci Nutr2022;62:3509-34

[51] Stojanov S,Štrukelj B.The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease.Microorganisms2020;8:1715 PMCID:PMC7692443

[52] DeJong EN,Bowdish DME.The gut microbiota and unhealthy aging: disentangling cause from consequence.Cell Host Microbe2020;28:180-9

[53] Turnbaugh PJ,Yatsunenko T.A core gut microbiome in obese and lean twins.Nature2009;457:480-4 PMCID:PMC2677729

[54] Aoun A,Hamod N.The influence of the gut microbiome on obesity in adults and the role of probiotics, prebiotics, and synbiotics for weight loss.Prev Nutr Food Sci2020;25:113-23 PMCID:PMC7333005

[55] Magne F,Gauthier L.The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?.Nutrients2020;12:1474 PMCID:PMC7285218

[56] Castaner O,Park YM.The gut microbiome profile in obesity: a systematic review.Int J Endocrinol2018;2018:4095789 PMCID:PMC5933040

[57] Peters BA,Church TR.A taxonomic signature of obesity in a large study of American adults.Sci Rep2018;8:9749 PMCID:PMC6021409

[58] Koutoukidis DA,Zimmerman M.The association of weight loss with changes in the gut microbiota diversity, composition, and intestinal permeability: a systematic review and meta-analysis.Gut Microbes2022;14:2020068 PMCID:PMC8796717

[59] Vaz M,Monteiro MP.Metabolomic signatures after bariatric surgery - a systematic review.Rev Endocr Metab Disord2022;23:503-19 PMCID:PMC9156502

[60] Tavassol ZH,Atlasi R.Alteration in gut microbiota composition of older adults is associated with obesity and its indices: a systematic review.J Nutr Health Aging2023;27:817-23

[61] Kesavelu D.Current understanding of antibiotic-associated dysbiosis and approaches for its management.Ther Adv Infect Dis2023;10:20499361231154443 PMCID:PMC9969474

[62] Malik JA,Lamba T,Khan MA.The impact of aging-induced gut microbiome dysbiosis on dendritic cells and lung diseases.Gut Microbes2023;15:2290643 PMCID:PMC10718154

[63] Hung CC,Huang CW,Cheng CH.Gut microbiota in patients with Alzheimer’s disease spectrum: a systematic review and meta-analysis.Aging2022;14:477-96 PMCID:PMC8791218

[64] Almeida HM,Conway J,Cavaglieri CR.Comparison between frail and non-frail older adults’ gut microbiota: a systematic review and meta-analysis.Ageing Res Rev2022;82:101773

[65] Palmas V,Madau V.Gut microbiota markers and dietary habits associated with extreme longevity in healthy sardinian centenarians.Nutrients2022;14:2436 PMCID:PMC9227524

[66] Biagi E,Rampelli S.Gut microbiota and extreme longevity.Curr Biol2016;26:1480-5

[67] Luan Z,Huang Y.Metagenomics study reveals changes in gut microbiota in centenarians: a cohort study of Hainan centenarians.Front Microbiol2020;11:1474 PMCID:PMC7343713

[68] Sepp E,Rööp T.Comparative analysis of gut microbiota in centenarians and young people: impact of eating habits and childhood living environment.Front Cell Infect Microbiol2022;12:851404 PMCID:PMC8965453

[69] Pang S,Lu Z.Longevity of centenarians is reflected by the gut microbiome with youth-associated signatures.Nat Aging2023;3:436-49

[70] Zhang S,Chen Y.Gut microbiota in healthy and unhealthy long-living people.Gene2021;779:145510

[71] Wilmanski T,Rappaport N.Gut microbiome pattern reflects healthy ageing and predicts survival in humans.Nat Metab2021;3:274-86 PMCID:PMC8169080

[72] Kaper JB,Mobley HLT.Pathogenic Escherichia coli.Nat Rev Microbiol2004;2:123-40

[73] Mohammad S.Role of metabolic endotoxemia in systemic inflammation and potential interventions.Front Immunol2020;11:594150 PMCID:PMC7829348

[74] Ghosh S,Garduño Jde J.Elevated muscle TLR4 expression and metabolic endotoxemia in human aging.J Gerontol A Biol Sci Med Sci2015;70:232-46 PMCID:PMC4311182

[75] Franceschi C,Parini P,Santoro A.Inflammaging: a new immune-metabolic viewpoint for age-related diseases.Nat Rev Endocrinol2018;14:576-90

[76] Crovesy L,Rosado EL.Profile of the gut microbiota of adults with obesity: a systematic review.Eur J Clin Nutr2020;74:1251-62

[77] Vatanen T, Kostic AD, d’Hennezel E, et al; DIABIMMUNE Study Group. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans.Cell2016;165:842-53 PMCID:PMC4950857

[78] Ahmad R,Bastola D,Singh AB.Obesity-induces organ and tissue specific tight junction restructuring and barrier deregulation by claudin switching.Sci Rep2017;7:5125 PMCID:PMC5505957

[79] Nagpal R,Wang S,Lovato JF.Obesity-linked gut microbiome dysbiosis associated with derangements in gut permeability and intestinal cellular homeostasis independent of diet.J Diabetes Res2018;2018:3462092 PMCID:PMC6140100

[80] Yao D,Dong M,Wu S.MUC2 and related bacterial factors: therapeutic targets for ulcerative colitis.EBioMedicine2021;74:103751 PMCID:PMC8671112

[81] Hussain M,Ahmad MI.Meat proteins in a high-fat diet have a substantial impact on intestinal barriers through mucus layer and tight junction protein suppression in C57BL/6J mice.Food Funct2019;10:6903-14

[82] Ghosh TS,O'Toole PW.The gut microbiome as a modulator of healthy ageing.Nat Rev Gastroenterol Hepatol2022;19:565-84 PMCID:PMC9035980

[83] Wu M, Wu Y, Li J, Bao Y, Guo Y, Yang W. The dynamic changes of gut microbiota in Muc2 deficient mice.Int J Mol Sci2018;19:2809 PMCID:PMC6164417

[84] Chen Z,Li J.Foxo1 controls gut homeostasis and commensalism by regulating mucus secretion.J Exp Med2021;218:e20210324 PMCID:PMC8424467

[85] Tran L.Age-associated remodeling of the intestinal epithelial barrier.J Gerontol A Biol Sci Med Sci2013;68:1045-56 PMCID:PMC3738030

[86] Oami T,Shimazui T.Claudin-2 upregulation enhances intestinal permeability, immune activation, dysbiosis, and mortality in sepsis.Proc Natl Acad Sci U S A2024;121:e2217877121 PMCID:PMC10927519

[87] Cuevas-Sierra A,Riezu-Boj JI,Martinez JA.Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications.Adv Nutr2019;10:S17-30 PMCID:PMC6363528

[88] Anachad O,Taha W,Chegdani F.The implication of short-chain fatty acids in obesity and diabetes.Microbiol Insights2023;16:11786361231162720 PMCID:PMC10041598

[89] Walters WA,Knight R.Meta-analyses of human gut microbes associated with obesity and IBD.FEBS Lett2014;588:4223-33 PMCID:PMC5050012

[90] Ecklu-Mensah G,Maseng MG.Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: the METS-microbiome study.Nat Commun2023;14:5160 PMCID:PMC10055249

[91] de la Cuesta-Zuluaga J,Álvarez-Quintero R.Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors.Nutrients2018;11:51 PMCID:PMC6356834

[92] Rampelli S,Turroni S.Functional metagenomic profiling of intestinal microbiome in extreme ageing.Aging2013;5:902-12 PMCID:PMC3883706

[93] Jones ML,Ganopolsky JG,Prakash S.The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention.Expert Opin Biol Ther2014;14:467-82

[94] Frommherz L,Hummel E.Age-related changes of plasma bile acid concentrations in healthy adults--results from the cross-sectional KarMeN study.PLoS One2016;11:e0153959 PMCID:PMC4836658

[95] Badal VD,Murray ER.The gut microbiome, aging, and longevity: a systematic review.Nutrients2020;12:3759 PMCID:PMC7762384

[96] Hersoug LG,Loft S.Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity.Nutr Res Rev2018;31:153-63

[97] Shi H,Inouye K,Yin H.TLR4 links innate immunity and fatty acid-induced insulin resistance.J Clin Invest2006;116:3015-25 PMCID:PMC1616196

[98] Ghosh AK,Mau T.Toll-like receptor 4 (TLR4) deficient mice are protected from adipose tissue inflammation in aging.Aging2017;9:1971-82 PMCID:PMC5636669

[99] Tilves CM,Kuipers AL.Association of lipopolysaccharide-binding protein with aging-related adiposity change and prediabetes among African ancestry men.Diabetes Care2016;39:385-91 PMCID:PMC4764043

[100] Liu X,Yao P.Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese.Diabetologia2014;57:1834-41

[101] Gomes JMG,Alfenas RCG.Metabolic endotoxemia and diabetes mellitus: a systematic review.Metabolism2017;68:133-44

[102] Kavanagh K,Davis AT,Rejeski WJ.Biomarkers of leaky gut are related to inflammation and reduced physical function in older adults with cardiometabolic disease and mobility limitations.Geroscience2019;41:923-33 PMCID:PMC6925090

[103] Brown GC.The endotoxin hypothesis of neurodegeneration.J Neuroinflammation2019;16:180 PMCID:PMC6744684

[104] Marizzoni M,Mirabelli P.Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer’s disease.J Alzheimers Dis2020;78:683-97

[105] Kesika P,Sivamaruthi BS.Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer’s disease.Life Sci2021;264:118627

[106] Lawrence JM,Wigdahl B.Roles of neuropathology-associated reactive astrocytes: a systematic review.Acta Neuropathol Commun2023;11:42 PMCID:PMC10009953

[107] Serrano-Pozo A,Gómez-Isla T.Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease.J Neuropathol Exp Neurol2013;72:462-71 PMCID:PMC3661683

[108] Ahmad MH,Mondal AC.Role of hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis and insulin signaling in the pathophysiology of Alzheimer’s disease.Neuropsychobiology2019;77:197-205

[109] Werdermann M,Scriba LD.Insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state.Mol Metab2021;43:101112 PMCID:PMC7691554

[110] Browning KN,Boeckxstaens GE.The vagus nerve in appetite regulation, mood, and intestinal inflammation.Gastroenterology2017;152:730-44 PMCID:PMC5337130

[111] Sen T,Ihde BT.Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity.Physiol Behav2017;173:305-17 PMCID:PMC5428886

[112] Phillips RJ,Powley TL.Age-related changes in vagal afferents innervating the gastrointestinal tract.Auton Neurosci2010;153:90-8 PMCID:PMC2818053

[113] Han Y,Gao H.Vagus nerve and underlying impact on the gut microbiota-brain axis in behavior and neurodegenerative diseases.J Inflamm Res2022;15:6213-30 PMCID:PMC9656367

[114] Marsh SE.Examining the mechanisms that link β-amyloid and α-synuclein pathologies.Alzheimers Res Ther2012;4:11 PMCID:PMC4054672

[115] Garvey WT, Mechanick JI, Brett EM, et al; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.Endocr Pract2016;22:1-203

[116] Hernández-Reyes A,Molina-Luque R,Molina-Recio G.Changes in body composition with a hypocaloric diet combined with sedentary, moderate and high-intense physical activity: a randomized controlled trial.BMC Womens Health2019;19:167 PMCID:PMC6935245

[117] Chao AM,Wadden TA.Dietary interventions for obesity: clinical and mechanistic findings.J Clin Invest2021;131:140065 PMCID:PMC7773341

[118] Di Rosa C,Spiezia C.Mediterranean diet versus very low-calorie ketogenic diet: effects of reaching 5% body weight loss on body composition in subjects with overweight and with obesity-a cohort study.Int J Environ Res Public Health2022;19:13040 PMCID:PMC9603454

[119] Bruci A,Tozzi R.Very low-calorie ketogenic diet: a safe and effective tool for weight loss in patients with obesity and mild kidney failure.Nutrients2020;12:333 PMCID:PMC7071259

[120] Dong TS,Lagishetty V.A high protein calorie restriction diet alters the gut microbiome in obesity.Nutrients2020;12:3221 PMCID:PMC7590138

[121] Tettamanzi F,Louca P.A high protein diet is more effective in improving insulin resistance and glycemic variability compared to a mediterranean diet-a cross-over controlled inpatient dietary study.Nutrients2021;13:4380 PMCID:PMC8707429

[122] Kheniser K,Kashyap SR.Long-term weight loss strategies for obesity.J Clin Endocrinol Metab2021;106:1854-66 PMCID:PMC8427732

[123] Machado AM,Bocardi VB.Understanding weight regain after a nutritional weight loss intervention: systematic review and meta-analysis.Clin Nutr ESPEN2022;49:138-53

[124] Jackson VM,Fortin JP.Latest approaches for the treatment of obesity.Expert Opin Drug Discov2015;10:825-39

[125] van Baak MA, Mariman ECM. Mechanisms of weight regain after weight loss - the role of adipose tissue.Nat Rev Endocrinol2019;15:274-87

[126] Perry AS,Risitano A.The inflammatory proteome, obesity, and medical weight loss and regain in humans.Obesity2023;31:150-8 PMCID:PMC9923277

[127] Fitzgerald KN,Hanes D.Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial.Aging2021;13:9419-32 PMCID:PMC8064200

[128] Waziry R,Corcoran DL.Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial.Nat Aging2023;3:248-57 PMCID:PMC10148951

[129] Lilja S,Krammer U.Five days periodic fasting elevates levels of longevity related christensenella and sirtuin expression in humans.Int J Mol Sci2021;22:2331 PMCID:PMC7956384

[130] McGrattan AM,McKinley MC.Diet and inflammation in cognitive ageing and Alzheimer’s disease.Curr Nutr Rep2019;8:53-65 PMCID:PMC6486891

[131] Filippou CD,Thomopoulos CG.Dietary approaches to stop hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials.Adv Nutr2020;11:1150-60 PMCID:PMC7490167

[132] Elsayed MM,El Refaye GE.Aerobic exercise with mediterranean-DASH intervention for neurodegenerative delay diet promotes brain cells’ longevity despite sex hormone deficiency in postmenopausal women: a randomized controlled trial.Oxid Med Cell Longev2022;2022:4146742 PMCID:PMC9001064

[133] Liu X,Dhana K.Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline.Contemp Clin Trials2021;102:106270 PMCID:PMC8042655

[134] Office for Health Improvement & Disparities. A consensus on healthy ageing. Available from: https://www.gov.uk/government/publications/healthy-ageing-consensus-statement/a-consensus-on-healthy-ageing. [Last accessed on 15 May 2024]

[135] Legrand R,Poulain M.Description of lifestyle, including social life, diet and physical activity, of people ≥ 90 years living in Ikaria, a longevity blue zone.Int J Environ Res Public Health2021;18:6602 PMCID:PMC8296328

[136] Fastame MC.Well-being, food habits, and lifestyle for longevity. Preliminary evidence from the sardinian centenarians and long-lived people of the Blue Zone.Psychol Health Med2022;27:728-33

[137] Zhang H,Diao Z,Zhang Y.Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: past and future.Genes Dis2021;8:38-47 PMCID:PMC7859422

[138] Sciorati C,Monno A.Pharmacological blockade of TNFα prevents sarcopenia and prolongs survival in aging mice.Aging2020;12:23497-508 PMCID:PMC7762456

[139] Amor C,Chowdhury S.Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction.Nat Aging2024;4:336-49 PMCID:PMC10950785

[140] Avcı A,Ulaş Y.Can biologic agents improve treatment success in obese patients with psoriasis vulgaris: a retrospective review of 320 patients with psoriasis vulgaris.Dermatol Pract Concept2024;14:e2024058 PMCID:PMC10868959

[141] Anghel F,Cristodor P.Body mass index influence for the personalization of the monoclonal antibodies therapy for psoriasis.Life2021;11:1316 PMCID:PMC8703749

[142] Patsalos O,Leppanen J,Himmerich H.Impact of TNF-α inhibitors on body weight and BMI: a systematic review and meta-analysis.Front Pharmacol2020;11:481 PMCID:PMC7174757

[143] Barros G,Vera I.Exploring the links between obesity and psoriasis: a comprehensive review.Int J Mol Sci2022;23:7499 PMCID:PMC9321445

[144] Grunvald E, Shah R, Hernaez R, et al; AGA Clinical Guidelines Committee. AGA clinical practice guideline on pharmacological interventions for adults with obesity.Gastroenterology2022;163:1198-225

[145] Chakhtoura M,Ghezzawi M,Tcheroyan R.Pharmacotherapy of obesity: an update on the available medications and drugs under investigation.EClinicalMedicine2023;58:101882 PMCID:PMC10041469

[146] Giruzzi N.Plenity (oral superabsorbent hydrogel).Clin Diabetes2020;38:313-4 PMCID:PMC7364464

[147] Suran M.As ozempic’s popularity soars, here’s what to know about semaglutide and weight loss.JAMA2023;329:1627-9

[148] Han SH,Ockerman K.Public interest in the off-label use of glucagon-like peptide 1 agonists (ozempic) for cosmetic weight loss: a google trends analysis.Aesthet Surg J2023;44:60-7

[149] Zhang Y,Niu Y.Research progress on aging mechanism and drugs and the role of stem cells in anti-aging process.Exp Gerontol2023;179:112248

[150] Mohammed I,Ding H.A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan.Front Endocrinol2021;12:718942 PMCID:PMC8374068

[151] Campbell JM,Stephenson MD.Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis.Ageing Res Rev2017;40:31-44

[152] U.S. Food and Drug Administration. GLUCOPHAGE® (metformin hydrochloride) tablets. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020357s037s039,021202s021s023lbl.pdf. [Last accessed on 15 May 2024]

[153] LaMoia TE.Cellular and molecular mechanisms of metformin action.Endocr Rev2021;42:77-96 PMCID:PMC7846086

[154] Kulkarni AS,Anghel V.Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults.Aging Cell2018;17:e12723 PMCID:PMC5847877

[155] U.S. Food and Drug Administration. Rapamune (sirolimus) Label. Highlights of prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s059,021110s076lbl.pdf. [Last accessed on 15 May 2024]

[156] Juricic P,Leech T.Long-lasting geroprotection from brief rapamycin treatment in early adulthood by persistently increased intestinal autophagy.Nat Aging2022;2:824-36 PMCID:PMC10154223

[157] Kulkarni AS,Berger DM,Kuchel GA.Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization.Aging Cell2022;21:e13596 PMCID:PMC9009114

[158] Ershad M,Vearrier D.N-acetylcysteine. Treasure island (FL): StatPearls Publishing; 2024.

[159] Sohouli MH,Malekpour Alamdari N.Effects of N-acetylcysteine on aging cell and obesity complications in obese adults: a randomized, double-blind clinical trial.Front Nutr2023;10:1237869 PMCID:PMC10546057

[160] U.S. Food and Drug Administration. Sprycel^TM (dasatinib) tablets. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021986s000_Sprycel__PRNTLBL.pdf. [Last accessed on 15 May 2024]

[161] Zhang L,Yousefzadeh MJ,Robbins PD.Cellular senescence: a key therapeutic target in aging and diseases.J Clin Invest2022;132:e158450 PMCID:PMC9337830

[162] Scarpellini E,Basilico M.From pre- and probiotics to post-biotics: a narrative review.Int J Environ Res Public Health2021;19:37 PMCID:PMC8750841

[163] Slavin J.Fiber and prebiotics: mechanisms and health benefits.Nutrients2013;5:1417-35 PMCID:PMC3705355

[164] Green M,Prakash S.Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome.Int J Mol Sci2020;21:2890 PMCID:PMC7215979

[165] Davani-Davari D,Karimzadeh I.Prebiotics: definition, types, sources, mechanisms, and clinical applications.Foods2019;8:92 PMCID:PMC6463098

[166] Canfora EE,Hermes GDA.Supplementation of diet with galacto-oligosaccharides increases bifidobacteria, but not insulin sensitivity, in obese prediabetic individuals.Gastroenterology2017;153:87-97.e3

[167] Arnold JW,Fabela S.The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut.Microbiome2021;9:31 PMCID:PMC7845053

[168] Qiang X,Qianbing W.Health benefit application of functional oligosaccharides.Carbohydr Polym2009;77:435-41

[169] Ma C,Wang Y.Anti-aging effect of agar oligosaccharide on male drosophila melanogaster and its preliminary mechanism.Mar Drugs2019;17:632 PMCID:PMC6891751

[170] D’Andrea G.Quercetin: a flavonol with multifaceted therapeutic applications?.Fitoterapia2015;106:256-71

[171] Jung CH,Ahn J,Ha TY.Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes.Phytother Res2013;27:139-43

[172] Cui Z,Amevor FK.Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism.Front Immunol2022;13:943321 PMCID:PMC9355713

[173] Saccon TD,Yadav H.Senolytic combination of dasatinib and quercetin alleviates intestinal senescence and inflammation and modulates the gut microbiome in aged mice.J Gerontol A Biol Sci Med Sci2021;76:1895-905 PMCID:PMC8514064

[174] Gonzales MM,Marques Zilli E.Senolytic therapy to modulate the progression of Alzheimer’s disease (SToMP-AD): a pilot clinical trial.J Prev Alzheimers Dis2022;9:22-9 PMCID:PMC8612719

[175] Zhao L,Xia M.Quercetin ameliorates gut microbiota dysbiosis that drives hypothalamic damage and hepatic lipogenesis in monosodium glutamate-induced abdominal obesity.Front Nutr2021;8:671353 PMCID:PMC8116593

[176] Shi T,Yao Z,Gao W.Quercetin improves gut dysbiosis in antibiotic-treated mice.Food Funct2020;11:8003-13

[177] Yuan H,Ling F.The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism, reducing inflammation and oxidative stress in high-fat diet-fed obese rats. Aging Cell 2020;19:e13199. PMCID:PMC7511879

[178] Huang LH,Wang LY,Hsu CH.Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial.BMC Complement Altern Med2018;18:294 PMCID:PMC6218972

[179] D'Amico D,Fouassier AM.Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis.Aging Cell2022;21:e13662 PMCID:PMC9381911

[180] Kong S,Cao H.Anti-obesity effects of galacto-oligosaccharides in obese rats.Eur J Pharmacol2022;917:174728

[181] Krumbeck JA,Hutkins RW.Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.Microbiome2018;6:121 PMCID:PMC6022452

[182] Hill C,Reid G.Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.Nat Rev Gastroenterol Hepatol2014;11:506-14

[183] Kechagia M,Konstantopoulou S.Health benefits of probiotics: a review.ISRN Nutr2013;2013:481651 PMCID:PMC4045285

[184] Singh RK,Yan D.Influence of diet on the gut microbiome and implications for human health.J Transl Med2017;15:73 PMCID:PMC5385025

[185] Tsai YC,Liu YW,Lee YK.Gerobiotics: probiotics targeting fundamental aging processes.Biosci Microbiota Food Health2021;40:1-11 PMCID:PMC7817508

[186] Tomaro-Duchesneau C,Malhotra M.Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats.Appl Microbiol Biotechnol2014;98:115-26

[187] Westfall S,Prakash S.A polyphenol-rich prebiotic in combination with a novel probiotic formulation alleviates markers of obesity and diabetes in Drosophila.J Funct Foods2018;48:374-86

[188] Iqbal UH,Prakash S.Novel microencapsulated probiotic blend for use in metabolic syndrome: design and in-vivo analysis.Artif Cells Nanomed Biotechnol2018;46:S116-24

[189] Lee E,Lee SY,Paik HD.Lactobacillus plantarum strain Ln4 attenuates diet-induced obesity, insulin resistance, and changes in hepatic mRNA levels associated with glucose and lipid metabolism.Nutrients2018;10:643 PMCID:PMC5986522

[190] van Beek AA,Hugenholtz F.Supplementation with Lactobacillus plantarum WCFS1 prevents decline of mucus barrier in colon of accelerated aging Ercc1^-/Δ7 mice.Front Immunol2016;7:408 PMCID:PMC5054004

[191] Lee CC,Lee MC.Lactobacillus plantarum TWK10 attenuates aging-associated muscle weakness, bone loss, and cognitive impairment by modulating the gut microbiome in mice.Front Nutr2021;8:708096 PMCID:PMC8548577

[192] Kang Y,Yang H.Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability.Pharmacol Res2022;175:106020

[193] Vallianou N,Christodoulatos GS,Dalamaga M.Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives.Curr Obes Rep2020;9:179-92

[194] Jang AY,Monmai C.Anti-inflammatory potential of Lactobacillus reuteri LM1071 via eicosanoid regulation in LPS-stimulated RAW264.7 cells.J Appl Microbiol2022;133:67-75

[195] Dias AMM,Hermetet F.Lactobacillus stress protein GroEL prevents colonic inflammation.J Gastroenterol2021;56:442-55

[196] Mu Q,Luo XM.Role of Lactobacillus reuteri in human health and diseases.Front Microbiol2018;9:757 PMCID:PMC5917019

[197] Jones ML,Prakash S.Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.J Clin Endocrinol Metab2013;98:2944-51

[198] Tenorio-Jiménez C,Tercero-Lozano M.Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).BMC Complement Altern Med2018;18:306 PMCID:PMC6245703

[199] Million M,Maraninchi M.Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli.Int J Obes2013;37:1460-6 PMCID:PMC3826031

[200] Álvarez-Arraño V.Effects of probiotics and synbiotics on weight loss in subjects with overweight or obesity: a systematic review.Nutrients2021;13:3627 PMCID:PMC8540110

[201] Chen LH,Chang HY.Probiotic supplementation attenuates age-related sarcopenia via the gut-muscle axis in SAMP8 mice.J Cachexia Sarcopenia Muscle2022;13:515-31 PMCID:PMC8818665

[202] Cheng LH,Hou AT,Shiu WL.Lactobacillus paracasei PS23 improves cognitive deficits via modulating the hippocampal gene expression and the gut microbiota in D-galactose-induced aging mice.Food Funct2022;13:5240-51

[203] Chen LH,Huang KC.Lactobacillus paracasei PS23 decelerated age-related muscle loss by ensuring mitochondrial function in SAMP8 mice.Aging2019;11:756-70 PMCID:PMC6366975

[204] Corpuz HM,Arimura M.Long-term diet supplementation with Lactobacillus paracasei K71 Prevents age-related cognitive decline in senescence-accelerated mouse prone 8.Nutrients2018;10:762 PMCID:PMC6024584

[205] Moro-García MA,Baltadjieva M.Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects.Age2013;35:1311-26 PMCID:PMC3705123

[206] Abdelhamid AG,El-Dougdoug NK.Probiotic Lactobacillus and Bifidobacterium strains possess safety characteristics, antiviral activities and host adherence factors revealed by genome mining.EPMA J2019;10:337-50 PMCID:PMC6883010

[207] Lee SY,Park JH,Ji GE.Bifidobacterium bifidum BGN4 paraprobiotic supplementation alleviates experimental colitis by maintaining gut barrier and suppressing nuclear factor kappa B activation signaling molecules.J Med Food2022;25:146-57

[208] Marras L,Bisicchia S.The role of bifidobacteria in predictive and preventive medicine: a focus on eczema and hypercholesterolemia.Microorganisms2021;9:836 PMCID:PMC8070932

[209] Rahman MS,Park DS.Bifidobacterium bifidum DS0908 and Bifidobacterium longum DS0950 culture-supernatants ameliorate obesity-related characteristics in mice with high-fat diet-induced obesity.J Microbiol Biotechnol2023;33:96-105 PMCID:PMC9899789

[210] Wang J,Zhu D.The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging - relevant neural and immune function.Gut Microbes2022;14:2107288 PMCID:PMC9361766

[211] Mo SJ,Hong HJ.Effects of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on overweight and the gut microbiota in humans: randomized, double-blinded, placebo-controlled clinical trial.Nutrients2022;14:2484 PMCID:PMC9228474

[212] Sohn M,Chu J,Kim BK.Efficacy and safety of Lactobacillus plantarum K50 on lipids in Koreans with obesity: a randomized, double-blind controlled clinical trial.Front Endocrinol2021;12:790046 PMCID:PMC8807682

[213] Rahayu ES,Putri Manurung NE.Effect of probiotic Lactobacillus plantarum Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults.World J Gastroenterol2021;27:107-28 PMCID:PMC7789061

[214] Michael DR,Jack AA.Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults.Sci Rep2021;11:5 PMCID:PMC7788077

[215] Aljumaah MR,Roach J,Azcarate Peril MA.The gut microbiome, mild cognitive impairment, and probiotics: a randomized clinical trial in middle-aged and older adults.Clin Nutr2022;41:2565-76

[216] Hwang YH,Paik JW.Efficacy and safety of Lactobacillus plantarum C29-Fermented Soybean (DW2009) in individuals with mild cognitive impairment: a 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial.Nutrients2019;11:305 PMCID:PMC6412773

[217] Kim CS,Sim M.Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community-dwelling older adults: a randomized, double-blind, placebo-controlled, multicenter trial.J Gerontol A Biol Sci Med Sci2021;76:32-40 PMCID:PMC7861012

[218] Asaoka D,Takeda T.Effect of probiotic bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: results of a 24-week randomized, double-blind, placebo-controlled trial.J Alzheimers Dis2022;88:75-95 PMCID:PMC9277669

[219] Fei Y,Lu J.Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment.Geriatr Nurs2023;51:167-75

[220] Shi S,Sang Y.Probiotic Bifidobacterium longum BB68S improves cognitive functions in healthy older adults: a randomized, double-blind, placebo-controlled trial.Nutrients2022;15:51 PMCID:PMC9824790

[221] Borges MK,Santos Siqueira AS,Cesari M.The relationship between physical frailty and mild cognitive impairment in the elderly: a systematic review.J Frailty Aging2019;8:192-7

[222] Quintero DF, Kok CR, Hutkins R. The future of synbiotics: rational formulation and design.Front Microbiol2022;13:919725 PMCID:PMC9354465

[223] Westfall S,Prakash S.Longevity extension in Drosophila through gut-brain communication.Sci Rep2018;8:8362 PMCID:PMC5976768

[224] Sergeev IN,Walton G.Effects of synbiotic supplement on human gut microbiota, body composition and weight loss in obesity.Nutrients2020;12:222 PMCID:PMC7019807

[225] Tripp ML,Eliason S.A low-glycemic, mediterranean diet and lifestyle modification program with targeted nutraceuticals reduces body weight, improves cardiometabolic variables and longevity biomarkers in overweight subjects: a 13-week observational trial.J Med Food2019;22:479-89

[226] Kopp L,Tingö L.Potential modulation of inflammation and physical function by combined probiotics, omega-3 supplementation and vitamin d supplementation in overweight/obese patients with chronic low-grade inflammation: a randomized, placebo-controlled trial.Int J Mol Sci2023;24:8567 PMCID:PMC10217964

[227] Saros L,Koivuniemi E.Fish oil and/or probiotics intervention in overweight/obese pregnant women and overweight risk in 24-month-old children.J Pediatr Gastroenterol Nutr2023;76:218-26 PMCID:PMC9848211

[228] Ford AL,Piano A.Microbiota stability and gastrointestinal tolerance in response to a high-protein diet with and without a prebiotic, probiotic, and synbiotic: a randomized, double-blind, placebo-controlled trial in older women.J Acad Nutr Diet2020;120:500-16.e10

[229] Crovesy L,Rosado EL.Modulation of the gut microbiota by probiotics and symbiotics is associated with changes in serum metabolite profile related to a decrease in inflammation and overall benefits to metabolic health: a double-blind randomized controlled clinical trial in women with obesity.Food Funct2021;12:2161-70

[230] Baştürk A,Yılmaz A.Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: a randomized controlled trial.Turk J Gastroenterol2016;27:439-43

[231] Salminen S,Endo A.The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.Nat Rev Gastroenterol Hepatol2021;18:649-67 PMCID:PMC8387231

[232] Lu Y,Li P,Chang X.Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota.Sci Rep2016;6:37589 PMCID:PMC5124860

[233] Hildebrand CB,Pich A.Short-chain fatty acids improve inflamm-aging and acute lung injury in old mice.Am J Physiol Lung Cell Mol Physiol2023;324:L480-92

[234] Arora K,Prakash S.The microbiome and Alzheimer’s disease: potential and limitations of prebiotic, synbiotic, and probiotic formulations.Front Bioeng Biotechnol2020;8:537847 PMCID:PMC7771210

[235] Kahouli I,Tomaro-Duchesneau C,Alaoui-Jamali MA. Identification of Lactobacillus Fermentum strains with potential against colorectal cancer by characterizing short chain fatty acids production, anti-proliferative activity and survival in an intestinal fluid: in vitro analysis. J Bioanal Biomed 2015;7:4. Available from: https://hal.science/hal-04021382v1/file/identification-of-lactobacillus-fermentum-strains-with-potential-against-colorectal-cancer-by-characterizing-1948-593X-1000132.pdf. [Last accessed on 15 May 2024]

[236] Westfall S,Singh SP.Ferulic acid produced by Lactobacillus fermentum NCIMB 5221 reduces symptoms of metabolic syndrome in Drosophila melanogaster.J Microb Biochem Technol2016;8:4

[237] de Melo TS,Carvalho KM.Ferulic acid lowers body weight and visceral fat accumulation via modulation of enzymatic, hormonal and inflammatory changes in a mouse model of high-fat diet-induced obesity.Braz J Med Biol Res2017;50:e5630 PMCID:PMC5264540

[238] DiNicolantonio JJ,Assanga SI,O’Keefe JH.Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity.Open Heart2022;9:e001801 PMCID:PMC8932268

[239] Fogelson KA,Zarrinpar A.The gut microbial bile acid modulation and its relevance to digestive health and diseases.Gastroenterology2023;164:1069-85 PMCID:PMC10205675

[240] Prete R,Gallardo AL,Corsetti A.Beneficial bile acid metabolism from Lactobacillus plantarum of food origin.Sci Rep2020;10:1165 PMCID:PMC6981223

[241] Mazloom K,Covasa M.Probiotics: how effective are they in the fight against obesity?.Nutrients2019;11:258 PMCID:PMC6412733

[242] Pérez-Ramos A,Coucheney F.Current knowledge of the mode of action and immunity mechanisms of LAB-bacteriocins.Microorganisms2021;9:2107 PMCID:PMC8538875

[243] Ahmad W,Abosalha A.High-molecular-weight dextran-type exopolysaccharide produced by the novel Apilactobacillus waqarii improves metabolic syndrome: in vitro and in vivo analyses.Int J Mol Sci2022;23:12692 PMCID:PMC9603972

[244] Lim J,Kim DH.Antiobesity effect of exopolysaccharides isolated from kefir grains.J Agric Food Chem2017;65:10011-9

[245] Zhang J,Jiang Y.Antioxidant status and gut microbiota change in an aging mouse model as influenced by exopolysaccharide produced by Lactobacillus plantarum YW11 isolated from Tibetan kefir.J Dairy Sci2017;100:6025-41